Dear John,
By 5 p.m. ET on Thursday, May 14, the Supreme Court is expected to decide whether to continue preserving telehealth and mail access to mifepristone, or allow a sweeping lower-court restriction to take effect.
As we remain on Supreme Court watch, here are two important perspectives to consider: Attorney Julie Kay and Ms. contributing editor Carrie Baker explore what today’s legal fight could mean for patients, providers and the future of abortion access nationwide; and legal analyst Joyce Vance’s latest breakdown of the Louisiana v. FDA case and what to watch for next. |
